German drugmaker Bayer said on Wednesday that its first phase experimental treatment for Parkinson’s disease had shown positive results.
And the German company Bayer stated that preliminary tests on humans showed that the experimental treatment with stem cells for Parkinson’s disease was well tolerated by patients, adding that the transplanted cells remained alive in their brains.
The company stated that the positive results over a year for the first phase of the treatment, which was carried out by Blurock Therapeutics, encouraged it to develop the treatment test on humans and move it to the second phase out of 3 stages.
It is noteworthy that this disease affects more than 10 million people in the world, and it is one of the health challenges that affect the elderly group in particular.
Although there are risk factors for infection at an advanced age, research indicates that it may also threaten younger groups.
2023-06-28 07:40:20
#Bayer #Positive #results #experimental #treatment #Parkinsons #disease
